The mission of Providence Medical Technology is to build a passionate team that delivers innovative spinal technology to help patients enjoy pain-free lives. The private corporation is focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to posterior cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to address the $2 billion worldwide cervical fusion market.

Cervical fusion is surgery that fuses together selected vertebrae in the neck, or cervical spine, to address painful neck problems such as degenerative disc disease. Traditional cervical fusion surgery involves accessing a patient's spine by entering through an incision at the front of the patient, in the throat area, around critical anatomy such as the esophagus and arteries. Providence creates products and procedures that support posterior cervical fusion surgery, which can use a tissue sparing incision to enter from the back of a patient's neck.

"We are committed to developing new products and procedures that are beneficial to patients, less expensive for responsible parties, and provide positive outcomes for both patients and surgeons," says CEO Jeff Smith.

Providence creates differentiated, high performing, innovative spinal implants and surgical instrumentation. One example is the DTRAX platform of cervical instruments, which are used to provide indirect decompression and fusion in patients suffering from cervical radiculopathy secondary to degenerative disc disease.

As healthcare costs continue to skyrocket, more surgeries will need to shift from traditional hospital operating rooms to ambulatory surgery centers, according to COO Ed Liou. He says Providence is proud to offer state of the art technology such as DTRAX in unique, sterile-shipped, single use systems uniquely positioned to work in the ambulatory surgery center setting due to simplified inventory and logistics.

In 2017, Providence released its FUSEBOX system, which features the CAVUX Cervical Cage-L device. The Cervical Cage-L device provides one of the the largest graft windows for bone growth of any comparable device available on the market, according to the company. In addition, it is also the only titanium, surface treated, stand-alone implant packaged in a complete, sterile, single use kit.

Worldwide, there have been more than 9,000 posterior cervical fusion surgeries performed with Providence Medical Technology products to date, according to Liou. "We have 13 peer-reviewed clinical publications including a randomized trial that show a favorable outcomes with low complication rates compared to other treatments," he says.

The company was officially founded in 2008. Providence moved its worldwide headquarters to Hacienda from Walnut Creek in November 2017. "Pleasanton meets our rapidly growing needs, and we're excited about its great proximity to public transit, skilled talent, transportation, and amenities," notes Liou about the company's Hacienda location. "It's also safe and central to both the East Bay and the 680 corridor."

The Hacienda headquarters has more than 40 employees; the company also has a significant sales and marketing presence both nationally and internationally. Employees at the Hacienda office chose to give back to the community in the fall of 2017 by volunteering at the Food Bank of Contra Costa and Solano counties.

To learn more about company events and developments, please follow it on Twitter at https://twitter.com/ProvidenceMT. To learn more about Providence Medical Technology, please visit providencemt.com.